HARP Harpoon Therapeutics Inc

Price (delayed)

$15.02

Market cap

$488.51M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.43

Enterprise value

$430.46M

Highlights
HARP's gross profit has soared by 189% YoY and by 33% QoQ
The company's revenue has surged by 189% YoY and by 33% QoQ
HARP's net income has shrunk by 99% QoQ and by 82% YoY
HARP's EPS has dropped by 72% since the previous quarter and by 52% year-on-year

Key stats

What are the main financial stats of HARP
Market
Shares outstanding
32.52M
Market cap
$488.51M
Enterprise value
$430.46M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.75
Price to sales (P/S)
20.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.59
Earnings
Revenue
$23.15M
EBIT
-$99.08M
EBITDA
-$96.59M
Free cash flow
-$9.9M
Per share
EPS
-$3.43
Free cash flow per share
-$0.31
Book value per share
$3.16
Revenue per share
$0.73
TBVPS
$8.28
Balance sheet
Total assets
$261.32M
Total liabilities
$158.94M
Debt
$13.28M
Equity
$102.38M
Working capital
$136.12M
Liquidity
Debt to equity
0.13
Current ratio
2.39
Quick ratio
2.34
Net debt/EBITDA
0.6
Margins
EBITDA margin
-417.2%
Gross margin
100%
Net margin
-427.9%
Operating margin
-431.8%
Efficiency
Return on assets
-48.7%
Return on equity
-137.2%
Return on invested capital
-81.2%
Return on capital employed
-60.7%
Return on sales
-427.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HARP stock price

How has the Harpoon Therapeutics stock price performed over time
Intraday
-2.34%
1 week
-2.02%
1 month
-26.3%
1 year
-18.28%
YTD
-9.57%
QTD
-28.2%

Financial performance

How have Harpoon Therapeutics's revenue and profit performed over time
Revenue
$23.15M
Gross profit
$23.15M
Operating income
-$99.99M
Net income
-$99.08M
Gross margin
100%
Net margin
-427.9%
HARP's gross profit has soared by 189% YoY and by 33% QoQ
The company's revenue has surged by 189% YoY and by 33% QoQ
HARP's net income has shrunk by 99% QoQ and by 82% YoY
HARP's operating income has dropped by 95% since the previous quarter and by 75% year-on-year

Growth

What is Harpoon Therapeutics's growth rate over time

Valuation

What is Harpoon Therapeutics stock price valuation
P/E
N/A
P/B
4.75
P/S
20.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.59
HARP's EPS has dropped by 72% since the previous quarter and by 52% year-on-year
The equity has soared by 90% from the previous quarter and by 23% YoY
The stock's price to book (P/B) is 30% less than its last 4 quarters average of 6.8
The company's revenue has surged by 189% YoY and by 33% QoQ
The stock's price to sales (P/S) is 37% less than its last 4 quarters average of 32.5

Efficiency

How efficient is Harpoon Therapeutics business performance
The company's return on equity has shrunk by 156% YoY and by 85% QoQ
Harpoon Therapeutics's return on invested capital has shrunk by 104% QoQ and by 44% YoY
HARP's return on assets has dropped by 75% since the previous quarter and by 42% year-on-year
HARP's return on sales is down by 50% since the previous quarter but it is up by 37% year-on-year

Dividends

What is HARP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HARP.

Financial health

How did Harpoon Therapeutics financials performed over time
Harpoon Therapeutics's total assets is 64% higher than its total liabilities
Harpoon Therapeutics's total liabilities has surged by 101% YoY and by 35% QoQ
Harpoon Therapeutics's total assets has surged by 61% YoY and by 52% QoQ
Harpoon Therapeutics's debt is 87% lower than its equity
The equity has soared by 90% from the previous quarter and by 23% YoY
HARP's debt to equity is down by 48% since the previous quarter and by 28% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.